Recently, MEOX2 has been implicated in fetal lung development and histopathological lung cancer progression [22], and MEOX2 and TWIST1 were previously associated with chemoresistance and lung cancer prognosis [21]. This evidence concerns the gene TWIST1 and lung carcinoma.